{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-084952","form_type":"8-K","ticker":"SLS","cik":"0001390478","company_name":"SELLAS Life Sciences Group, Inc.","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.876133+00:00","generated_at":"2026-05-31T13:43:49.266065+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"SELLAS Life Sciences raises $21M in registered direct offering at premium to market","bullets":["Gross proceeds of ~$21M from sale of 15,849,056 units (share or pre-funded warrant + warrant) at $1.325/unit.","Warrants exercisable for 15,849,056 shares at $1.20, immediately exercisable, five-year term.","Maxim Group acted as sole placement agent; offering priced at premium to market reflecting investor demand.","Offering closed on August 1, 2024, under effective shelf registration statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-084952","json":"https://secwatch.observer/filing/0001104659-24-084952.json","markdown":"https://secwatch.observer/filing/0001104659-24-084952.md","text":"https://secwatch.observer/filing/0001104659-24-084952.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924084952/0001104659-24-084952-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924084952/tm2420683d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:43:49.266065+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}